Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Briacell Therapeutics Corp T.BCT

Alternate Symbol(s):  BCTX | BCTXW

Healthcare Biotechnology
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted... see more

Recent & Breaking News (TSX:BCT)

IIROC Trading Resumption - BCT

Canada NewsWire June 3, 2021

BriaCell Therapeutics Corp. Announces US$27.2 Million Private Placement

GlobeNewswire June 3, 2021

IIROC Trading Halt - BCT

Canada NewsWire June 3, 2021

BriaCell Reports 12.0 Months Overall Survival Benefit in Advanced Breast Cancer; 100% Resolution of 'Eye-Bulging' Tumor

GlobeNewswire June 2, 2021

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

GlobeNewswire May 19, 2021

BriaCell to Participate at Upcoming Conferences and Appoints Senior R&D Director

GlobeNewswire May 11, 2021

BriaCell CEO Gives Corporate Overview, Plans for Future in Audio Interview with SmallCapVoice.com

GlobeNewswire April 21, 2021

BriaCell Announces Investor and Media Outreach Programs

GlobeNewswire April 15, 2021

BriaCell Therapeutics (TSXV:BCT) presents clinical data at the American Association for Cancer Research (AACR) Annual Meeting 2021

Brieanna McCutcheon  April 12, 2021

BriaCell (TSXV:BCT) announces closing of the over-allotment option in connection with U.S. public offering

John Ballem  April 12, 2021

BriaCell Announces Closing of Over-Allotment Option in Connection with U.S. Public Offering, Bringing Total Gross Proceeds to US$28.7 Million

GlobeNewswire April 12, 2021

BriaCell Therapeutics Presents Clinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2021

GlobeNewswire April 12, 2021

BriaCell Therapeutics to Present at the American Association for Cancer Research Annual Meeting 2021

GlobeNewswire March 30, 2021

BriaCell Announces Closing of US$25 Million Public Offering

GlobeNewswire February 26, 2021

BriaCell Announces Pricing of US$25 Million Public Offering and Nasdaq Listing

GlobeNewswire February 23, 2021

BriaCell Presents Clinical Data at 2021 Keystone Symposium

GlobeNewswire January 26, 2021

BriaCell Announces Presentation at the 2021 Keystone Symposia Conference: Emerging Cell Therapies

GlobeNewswire January 12, 2021

BriaCell Presents Clinical Data at the 2020 San Antonio Breast Cancer Symposium®

GlobeNewswire December 9, 2020

BriaCell Appoints Martin Schmieg to Board of Directors

GlobeNewswire December 1, 2020

BriaCell Announces Collaboration with the National Cancer Institute

GlobeNewswire November 10, 2020